Farallon Capital Management LLC Forte Biosciences, Inc. Transaction History
Farallon Capital Management LLC
- $21.4 Billion
- Q1 2024
A detailed history of Farallon Capital Management LLC transactions in Forte Biosciences, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 1,810,455 shares of FBRX stock, worth $1.03 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,810,455
Previous 1,810,455
-0.0%
Holding current value
$1.03 Million
Previous $1.27 Million
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding FBRX
# of Institutions
34Shares Held
19MCall Options Held
1KPut Options Held
0-
Tybourne Capital Management (Hk) LTD Hong Kong, K33.62MShares$2.07 Million0.57% of portfolio
-
Perceptive Advisors LLC New York, NY3.27MShares$1.86 Million0.05% of portfolio
-
Bvf Inc San Francisco, CA2.98MShares$1.7 Million0.06% of portfolio
-
Cable Car Capital LLC San Francisco, CA2.03MShares$1.16 Million1.95% of portfolio
-
Fred Alger Management, LLC New York, NY1.84MShares$1.05 Million0.01% of portfolio
About Forte Biosciences, Inc.
- Ticker FBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,340,300
- Market Cap $11.6M
- Description
- Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.